|
2025
|
P/S
|
Promoting awareness of patient support services and resources for gastrointestinal and other comp... |
|
2024
|
Invention
|
Delayed release compositions of linaclotide.
The present invention relates to delayed release ph... |
|
|
P/S
|
Research and development of pharmaceuticals for others; Research and development of pharmaceutica... |
|
|
Invention
|
Compositions for colon cleansing and the treatment of gastrointestinal disorders.
The present in... |
|
2023
|
Invention
|
Treatment of constipation-predominant irritable bowel syndrome.
The invention provides methods f... |
|
|
Invention
|
Low-dose stable formulations of linaclotide.
The present invention relates to stable pharmaceuti... |
|
|
Invention
|
Treatment of abdominal pain associated with diarrhea-predominant irritable bowel syndrome.
The i... |
|
|
Invention
|
Stable formulations of linaclotide.
The present invention relates to stable pharmaceutical compo... |
|
|
Invention
|
Treatments for gastrointestinal disorders.
The present invention features peptides, compositions... |
|
|
Invention
|
Stable solid formulation of gc-c receptor agonist polypeptide suitable for oral administration.
... |
|
|
Invention
|
Methods of treating upper gastrointestinal disorders in ppi refractory gerd.
Disclosed herein ar... |
|
2022
|
Invention
|
Pharmaceutical compositions for the treatment of visceral pain. The present disclosure provides p... |
|
|
Invention
|
Synthetic process for production of modified gcc receptor agonists. The present invention relates... |
|
|
Invention
|
Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant.
Disclosed herein... |
|
|
Invention
|
Modified or targeted release formulations of linaclotide.
The present invention relates to delay... |
|
2021
|
Invention
|
Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration.... |
|
|
P/S
|
provision of medical and health care information regarding pharmaceuticals for treatment of chron... |
|
2020
|
Invention
|
Treatment of abdominal pain associated with diarrhea-predominant irritable bowel syndrome. The in... |
|
2019
|
Invention
|
Method of generating anti-linaclotide antibodies and uses thereof.
The invention provides a meth... |
|
2018
|
Invention
|
Treatment of metabolic syndrome with an sgc stimulator. The present invention provides a method o... |
|
|
Invention
|
Efficacy of a gastro-retentive bile acid sequestrant dosage form.
Methods and formulations of re... |
|
|
Invention
|
Method of detecting and quantifying bile acid from saliva.
A method of detecting and quantifying... |
|
|
Invention
|
Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators. The p... |
|
2017
|
P/S
|
Pharmaceutical preparations. |
|
2016
|
P/S
|
Pharmaceutical preparations for use in the treatment of digestive and gastrointestinal related di... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of
digestive and gastrointestinal related d... |
|
2015
|
P/S
|
pharmaceutical preparations for use in the treatment of digestive and gastrointestinal related di... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of chronic idiopathic ... |
|
2014
|
P/S
|
Pharmaceutical preparations for use in the treatment various disorders and diseases, namely, canc... |
|
2012
|
P/S
|
pharmaceutical preparations for use in the treatment of chronic constipation, irritable bowel syn... |
|
2011
|
P/S
|
Pharmaceutical preparations for use in the treatment of chronic constipation, irritable bowel syn... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of
chronic constipation, irritable bowel sy... |
|
|
P/S
|
printed matter, namely, brochures, pamphlets, promotional materials, patient educational material... |
|
|
P/S
|
medical informational services, namely, providing health information in the field of chronic cons... |
|
2008
|
P/S
|
Pharmaceutical preparations for use in the treatment of
cancer, allergies, inflammation, pain, m... |
|
2007
|
P/S
|
research and development of pharmaceuticals for others |
